| Thursday, Nov 19, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 13:00-17:30 | Hands-on Workshop on Preparation of Ovarian Tissue for Cryopreservation Chairs: Debra Gook, Australia and Claus Yding Andersen, Denmark | 13:00-17:30 | Oncofertility 101 |
The workshop will include:
|
13:00-13:10 | Welcome and Introduction to Oncofertility Molly Moravek, Henry Ford Health, MI, USA | |
| 13:10-13:55 | Female Fertility Preservation Molly Moravek, Henry Ford Health, MI, USA | ||
| 13:55-14:40 | Male Fertility Preservation James Smith, UCSF, CA, USA | ||
| 14:40-15:25 | Pediatric Fertility Preservation Tyler Ketterl, University of Washington, WA, USA | ||
| 15:25-15:40 | Break | ||
| 15:40-16:25 | Effective Patient Navigation Kristin Smith, BS, Northwestern Medicine, IL, USA | ||
| 16:25-17:30 | How to Build a Comprehensive Fertility Preservation Program Joseph Letourneau and Douglas Fair, University of Utah, UT, USA | ||
| 17:30-18:30 | Technical break | ||
| 18:30-18:45 | Inauguration of the Conference Claus Yding Andersen, Denmark and Pasquale Patrizio, USA | ||
| 18:45-19:15 | Honorary Lecture 1 Chairs: Pasquale Patrizio, USA and Glenn Schattman, USA Cancer, endometriosis and neurological dysfunction linked by immune therapies in human medicine: Alan Trounson, Australia |
||
| 19:15 | Welcome Reception | ||
| Friday, Nov 20, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 08:30-09:00 | Honorary Lecture 2 Chair: Claus Yding Andersen, Denmark Perspectives on fertility preservation in cancer patients: How to balance an urgent need for treatment and desire to reproduce Hamish Wallace, UK |
||
| 09:00-10:15 | Session 1A: Cancer therapy and fertility preservation Chairs: Kenny Rodriguez-Wallberg, Sweden and Zev Rosenwaks, USA |
09:00-10:15 | Session 1B: New and experimental approaches in fertility preservation Chairs: Pasquale Patrizio, USA and Miran Kim, South Korea |
| 09:00-09:20 | Novel and upcoming cancer therapies: are they gonadotoxic? Roy Herbst, USA | 09:00-09:20 | Ovarian tissue freezing for fertility preservation in patients with hemoglobin disorders: Rebecca Flyckt, USA |
| 09:20-09:40 | Impact of new antibody-based cancer treatments on fertility: Karla Hutt, Australia | 09:20-09:40 | Peripubertal ovarian stimulation for oocyte freezing in young girls with Turner’s syndrome: Ozgur Oktem, Turkey |
| 09:40-10:00 | Biological mechanisms of treatment-induced gonadotoxicity with the new anticancer therapies: Isabelle Demeestere, Belgium | 09:40-10:00 | Prediction of outcomes from oocytes and sperm to improve counseling: Charles Bormann, USA |
| 10:00-10:15 | Q&A | 10:00-10:15 | Q&A |
| 10:15-10:45 | Coffee Break | ||
| 10:45-12:00 | Session 2A: Ovarian Protection and Mechanisms of Gonadotoxicity Chairs: Dror Meirow, Israel and TBA |
10:45-12:00 | Session 2B: Expanding fertility preservation and impact of new cancer treatments Chairs: Kristin Smith, USA and Michael von Wolff, Switzerland |
| 10:45-11:05 | DNA damage and repair in the preantral follicle pool following radiotherapy: Luciana Cacciottola, France | 10:45-11:05 | Preserving versus restoring fertility-restorative reproductive medicine is not enough: Terri Woodard, USA |
| 11:05-11:25 | Insights gained from studies investigating chemotherapy effects on the ovaries: Dror Meirow, Israel | 11:05-11:25 | Innate inflammatory signaling drives ovotoxicity downstream of alkylating chemotherapy and can be pharmacologically targeted for fertoprotection: Limor Man, USA |
| 11:25-11:45 | Allogenic transplantation of ovarian tissue-update: Sherman Silber, USA | 11:25-11:45 | Ovarian tissue cryopreservation in China including a program on transportation prior to freezing: Xiangyan Ruan, China |
| 11:45-12:00 | Q&A | 11:45-12:00 | Q&A |
| 12:00-13:15 | Session 3A: Fertility preservation with Ovarian Malignancy Chairs: Abed Sinno, USA and Nao Suzuki, Japan |
12:00-13:15 | Session 3B: Oral Session of selected posters Chairs: Debra Gook, Australia and Molly Moravek, USA |
| 12:00-12:20 | Ex-vivo retrievals for patients with ovarian malignancy: How to coordinate treatment: Glenn Schattman, USA | 12:00-12:12 | Oral presentation 1 |
| 12:20-12:45 | Fertility preservation in borderline ovarian tumors; what if the contralateral ovary is ok? Nao Suzuki, Japan | 12:12-12:24 | Oral presentation 2 |
| 12:24-12:36 | Oral presentation 3 | ||
| 12:45-13:05 | Freeze both ovaries in connection with bone marrow transplantation? – Pro and con: Catherine Poirot, France | 12:36-12:48 | Oral presentation 4 |
| 13:05-13:20 | Q&A | 12:48-13:00 | Oral presentation 5 |
| 13:00-13:15 | Oral presentation 6 | ||
| 13:20-14:00 | Lunch | ||
| Oncology afternoon | |||
| 14:00-15:15 | Session 4A: Fertility Preservation Hematological and Gynecological Cancers (Sylvester Cancer Center) Chairs: Stephen Nimer, USA and Pasquale Patrizio, USA | 14:00-15:15 | Session 4B: Fertility Preservation in boys Chairs: Kyle Orwig, USA and Ellen Goossens, Belgium |
| 14:00-14:20 | Genetic markers and therapeutic solutions for leukemia Stephen Nimer, USA | 14:00-14:20 | Worldwide activity – amount of tissue frozen-methods Rod Mitchell, UK |
| 14:20-14:40 | Ovarian tissue transplantation in acute leukemia: balancing the risk of relapses and the hope of parenthood Florian Chevillon, France | 14:20-14:40 | Transplantation of adult frozen/thawed testicular tissue as a model to develop a method for fertility restoration Claus Yding Andersen, Denmark |
| 14:40-15:00 | Fertility preservation in cervical cancer Abed Sinno, USA | 14:40-15:00 | Obtaining chromosomal normal spermatogonial stem cells in Klinefelter Syndrome patients Hooman Sadri-Ardekani, USA |
| 15:00-15:15 | Q&A | 15:00-15:15 | Q&A |
| 15:15-16:30 | Session 5A: Oncology-Breast Cancer patients and Fertility Preservation Chairs: Carmen Calfa, USA and Kenny Rodriguez-Wallberg, Sweden |
15:15-16:30 | Session 5B: In Vitro Maturation of Human Oocytes in connection with freezing ovarian tissue Chairs: Xiaoyan Liang, China and Jesus Cadenas, Denmark |
| 15:15-15:35 | Update on efficacy and safety of fertility preservation in patients with breast cancer: Moran Shapira, Israel | 15:15-15:35 | IVM experience from Vietnam: Ho Tuong, Vietnam |
| 15:35-15:55 | Oncologic and reproductive outcomes after fertility preservation in women with breast cancer – the needed long-term observation time: Kenny Rodriguez-Wallberg, Sweden | 15:35-15:55 | IVM in connection with OTC – experience from China: Xiaoyan Liang, China |
| 15:55-16:15 | How to expand coverage of fertility preservation: how to approach legislators and inclusion of patients: Joyce Reinecke, USA | 15:55-16:15 | Techniques for aspiration of human small antral follicles (2–5 mm) without general anesthesia: Kristine Løssl, Denmark |
| 16:15-16:30 | Q&A | 16:15-16:30 | Q&A |
| 16:30-16:45 | Coffee Break | ||
| 16:45-18:00 | Session 6A: Fertility preservation: Testicular Tissue Cryopreservation and beyond Chairs: Rod Mitchell, UK and Hooman Sadri-Ardekani, USA |
16:45-18:00 | Session 6B: Understanding human folliculogenesis Chairs: Debra Gook, Australia and Claus Yding Andersen, Denmark |
| 16:45-17:05 | Indications – genetic conditions – cryptorchidism – cancer: Emilie Johnson, USA | 16:45-17:05 | Engineering strategies for the follicular micro-environment: Monica Laronda, USA |
| 17:05-17:25 | Experience with transplantation of prepubertal human testicular tissue: Ellen Goossens, Belgium | 17:05-17:25 | Update on progress of human in vitro follicle activation – any clinical solutions in sight? David Albertini, USA |
| 17:25-17:45 | Fertility Preservation and Restoration with Testicular Tissues and Cells: Kyle Orwig, USA | 17:25-17:45 | New drugs/agonists to prevent or initiate initiation of follicular growth (AMH, GDF9, others): Laura Detti, USA |
| 17:45-18:00 | Q&A | 17:45-18:00 | Q&A |
| 19:00-22:00 | Social Event | ||
| Saturday, Nov 21, 2026 | |||
|---|---|---|---|
| Hall A | Hall B | ||
| 08:30-09:00 | Honorary Lecture 3: Chairs: Dror Meirow, Israel and Claus Yding Andersen, Denmark Generation of spermatogonia from human and nonhuman primate pluripotent stem cells Kotaro Sasaki, USA |
||
| 09:00-10:15 | Session 7A: Ovarian Tissue Cryopreservation in Children and Adolescents Chairs: Kenny Rodriguez-Wallberg, Sweden and Leslie Appiah, USA |
09:00-10:15 | Session 7B: AI in fertility preservation Chairs: Pasquale Patrizio, USA and Jung Ryeol Lee, South Korea |
| 09:00-09:20 | Indications and worldwide activity of fertility preservation in prepubertal girls: Elizabeth Ginsburg, USA | 09:00-09:20 | Novel fertility preservation approaches using stem cells and exosomes: Ayman Al-Hendy, USA |
| 09:20-09:40 | Fertility preservation in girls, OTC and OTT in girls with thalassemia and sickle cell anemia: Xiaoyan Liang, China | 09:20-09:40 | Use of AI and robotics combined with microscopy-/ultrasound to select for strips of the most follicle-rich tissue in procurement of ovarian tissue: Ariella Shikanov, USA |
| 09:40-10:00 | Freezing ovarian tissue from young prepubertal girls – technical aspects: Debbie Gook, Australia | 09:40-10:00 | Breakthroughs in fertility preservation: innovative approaches for immediate and long-term care: Amir Arav, Israel |
| 10:00-10:15 | Q&A | 10:00-10:15 | Q&A |
| 10:15-10:45 | Coffee Break | ||
| 10:45-12:00 | Session 8A: Ovarian Tissue Transplantation Chairs: Nao Suzuki, Japan and Dror Meirow, Israel |
10:45-11:57 | Session 8B: Oral Session of selected posters Chairs: Monica Laronda, USA and Kristin Smith, USA |
| 10:45-11:05 | Ovarian tissue transplantation: Worldwide activity, results, and recurrence: Michael von Wolff, Switzerland | 10:45-10:57 | Oral presentation 1 |
| 11:05-11:25 | Which site to transplant – does ovulation occur from the peritoneal pocket positioned tissue? Isabelle Demeestere, Belgium | 10:57-11:09 | Oral presentation 2 |
| 11:09-11:21 | Oral presentation 3 | ||
| 11:25-11:45 | Cancer survivorship: enhancing well-being beyond cancer treatment: Frank Penedo, USA | 11:21-11:33 | Oral presentation 4 |
| 11:45-12:00 | Q&A | 11:33-11:45 | Oral presentation 5 |
| 11:45-11:57 | Oral presentation 6 | ||
| 12:00-13:15 | Session 9A: Longevity of ovarian function Chairs: Glenn Schattman, USA and Jung Ryeol Lee, South Korea |
12:00-13:12 | Session 9B: Oral Session of selected posters Chairs: Claus Yding Andersen, Denmark and Zev Rosenwaks, USA |
| 12:00-12:20 | Predictive markers for longevity of transplanted ovarian tissue – beyond age: Debra Gook, Australia | 12:00-12:12 | Oral presentation 1 |
| 12:20-12:45 | Ex vivo ovarian perfusion: Folliculogenesis and oocyte retrievals after gonadotropins: Pasquale Patrizio, USA | 12:12-12:24 | Oral presentation 2 |
| 12:45-13:05 | Understanding molecular mechanism of freeze-thaw injury after OTC and oocyte cryopreservation and how to improve preservation: Wen Li, China | 12:24-12:36 | Oral presentation 3 |
| 12:36-12:48 | Oral presentation 4 | ||
| 13:05-13:20 | Q&A | 12:48-13:00 | Oral presentation 5 |
| 13:00-13:12 | Oral presentation 6 | ||
| 13:20-14:00 | Lunch | ||
| 14:00-15:15 | Session 10A: Artificial Ovaries, artificial follicle formation, gonadal IPSc Chairs: Debra Gook, Australia and Monica Laronda, USA |
14:00-15:15 | Session 10B: Oncology and fertility preservation Chairs: Kenny Rodriguez-Wallberg, Sweden and Larisa Gavrilova-Jordan, USA |
| 14:00-14:20 | Restoring steroidogenesis using hPSC-derived GPCs-initially for securing endocrine function after menopause? Daylon James, USA | 14:00-14:20 | Hormonal replacement strategies in survivors of Gynecological cancers: Abed Sinno, USA |
| 14:20-14:40 | Artificial ovaries for fertility and hormone therapy :Jung Ryeol Lee, South Korea | 14:20-14:40 | Breast Cancer and Fertility – challenges and opportunities : Carmen Calfa, USA |
| 14:40-15:00 | Induction of male neogametogenesis in a 3D microenvironment supporting successful fertilization and proper embryo development: Gianpiero Palermo, USA | 14:40-15:00 | Effects of letrozole during ovarian stimulation in circulation and in the follicle: Claus Yding Andersen, Denmark |
| 15:00-15:15 | Q&A | 15:00-15:15 | Q&A |
| 15:15-16:30 | Session 11A: Fertility Preservation in Endometriosis and Uterus Surgery Chairs: Tommaso Falcone, USA and Nao Suzuki, Japan |
15:15-16:27 | Session 11B: Oral Session of selected posters Chairs: Jung Ryeol Lee, South Korea and Terri Woodard, USA |
| 15:15-15:35 | Uterine surgery to preserve fertility through uterus conservation in fibromyomatosis/ adenomyosis: Tommaso Falcone, USA | 15:15-15:27 | Oral presentation 1 |
| 15:35-15:55 | Uterus transplantation: An update: Mats Brännström, Sweden | 15:27-15:39 | Oral presentation 2 |
| 15:55-16:15 | Fertility preservation in connection with endometriosis: Tommaso Falcone, USA | 15:39-15:51 | Oral presentation 3 |
| 15:51-16:03 | Oral presentation 4 | ||
| 16:15-16:30 | Q&A | 16:03-16:15 | Oral presentation 5 |
| 16:15-16:27 | Oral presentation 6 | ||
| 16:30-16:45 | Coffee Break | ||
| 16:45-18:00 | Session 12A: Cancer survivorship-Sylvester cancer center Chairs: Abed Sinno, USA and Roy Herbst, USA |
16:45-18:00 | Session 12B: Understanding IVM Chairs: Xiaoyan Liang, China and Claus Yding Andersen, Denmark |
| 16:45-17:05 | Supporting the reproductive health of adolescent girls who are pediatric cancer survivors: Judy Simms-Cendan, USA | 16:45-17:05 | How does CAPA-IVM work and is there other solutions to optimize oocyte maturation: Ri-Cheng Chian, China |
| 17:05-17:25 | Safety of pregnancy after breast cancer: what is current evidence: Luca Arecco , Belgium | 17:05-17:25 | Two for one: Combining OTC with IVM from medullary antral follicles: results of combined approaches in Denmark: Jesus Cadenas, Denmark |
| 17:25-17:45 | Harnessing circadian biology to optimize cancer treatment response: Tracy Crane, USA | 17:25-17:45 | Does co-culture of hIPS cell-derived ovarian support cells improve IVM? Christian Kramme, USA |
| 17:45-18:00 | Q&A | 17:45-18:00 | Q&A |
| 18:00-18:30 | Adjourn and Closing Ceremony Claus Yding Andersen, Denmark and Pasquale Patrizio, USA | ||
| Thursday, Nov 19, 2026 | |
|---|---|
| Hall A | Hall B |
| 13:00-17:30 Hands-on Workshop on Preparation of Ovarian Tissue for Cryopreservation Chairs: Debra Gook, Australia and Claus Yding Andersen, Denmark |
13:00-17:30 Oncofertility 101 |
| 13:00-13:10 Welcome and Introduction to Oncofertility Molly Moravek, Henry Ford Health, MI, USA |
|
| 13:10-13:55 Female Fertility Preservation Molly Moravek, Henry Ford Health, MI, USA |
|
| 13:55-14:40 Male Fertility Preservation James Smith, UCSF, CA, USA |
|
| 14:40-15:25 Pediatric Fertility Preservation Tyler Ketterl, University of Washington, WA, USA |
|
| 15:25-15:40 Break |
|
| 15:40-16:25 Effective Patient Navigation Kristin Smith, BS, Northwestern Medicine, IL, USA |
|
| 16:25-17:30 How to Build a Comprehensive Fertility Preservation Program Joseph Letourneau and Douglas Fair, University of Utah, UT, USA |
|
| 17:30-18:30 Technical break |
|
| 18:30-18:45 Inauguration of the Conference Claus Yding Andersen, Denmark and Pasquale Patrizio, USA |
|
| 18:45-19:15 Honorary Lecture 1 Chairs: Pasquale Patrizio, USA and Glenn Schattman, USA Ovarian cancer/Endometriosis: new treatment models Alan Trounson, Australia |
|
| 19:15 Welcome Reception |
|
| Friday, Nov 20, 2026 | |
|---|---|
| Hall A | Hall B |
| 08:30-09:00 Honorary Lecture 2 Chair: Claus Yding Andersen, Denmark Perspectives on fertility preservation in cancer patients: How to balance an urgent need for treatment and desire to reproduce Hamish Wallace, UK |
|
| 09:00-10:15 Session 1A: Cancer therapy and fertility preservation Chairs: Kenny Rodriguez-Wallberg, Sweden and Zev Rosenwaks, USA |
09:00-10:15 Session 1B: New and experimental approaches in fertility preservation Chairs: Pasquale Patrizio, USA and Miran Kim, South Korea |
| 09:00-09:20 Novel and upcoming cancer therapies: are they gonadotoxic? Roy Herbst, USA |
09:00-09:20 Ovarian tissue freezing for fertility preservation in patients with hemoglobin disorders Rebecca Flyckt, USA |
| 09:20-09:40 Impact of new antibody-based cancer treatments on fertility Karla Hutt, Australia |
09:20-09:40 Peripubertal ovarian stimulation for oocyte freezing in young girls with Turner’s syndrome Ozgur Oktem, Turkey |
| 09:40-10:00 Biological mechanisms of treatment-induced gonadotoxicity with the new anticancer therapies Isabelle Demeestere, Belgium |
09:40-10:00 Prediction of outcomes from oocytes and sperm to improve counseling Charles Bormann, USA |
| 10:00-10:15 Q&A |
10:00-10:15 Q&A |
| 10:15-10:45 Coffee Break |
|
| 10:45-12:00 Session 2A: Ovarian Protection and Mechanisms of Gonadotoxicity Chairs: Dror Meirow, Israel and Nalini Kaul Mahajan, India |
10:45-12:00 Session 2B: Expanding fertility preservation and impact of new cancer treatments Chairs: Kristin Smith, USA and Michael von Wolff, Switzerland |
| 10:45-11:05 DNA damage and repair in the preantral follicle pool following radiotherapy Luciana Cacciottola, France |
10:45-11:05 Preserving versus restoring fertility-restorative reproductive medicine is not enough Terri Woodard, USA |
| 11:05-11:25 Insights gained from studies investigating chemotherapy effects on the ovaries Dror Meirow, Israel |
11:05-11:25 Innate inflammatory signaling drives ovotoxicity downstream of alkylating chemotherapy and can be pharmacologically targeted for fertoprotection Limor Man, USA |
| 11:25-11:45 Allogenic transplantation of ovarian tissue-update Sherman Silber, USA |
11:25-11:45 Ovarian tissue cryopreservation in China including a program on transportation prior to freezing Xiangyan Ruan, China |
| 11:45-12:00 Q&A |
11:45-12:00 Q&A |
| 12:00-13:15 Session 3A: Fertility preservation with Ovarian Malignancy Chairs: Abed Sinno, USA and Nao Suzuki, Japan |
12:00-13:15 Session 3B: Oral Session of selected posters Chairs: Debra Gook, Australia and Molly Moravek, USA |
| 12:00-12:20 Ex-vivo retrievals for patients with ovarian malignancy: How to coordinate treatment Glenn Schattman, USA |
12:00-12:12 Oral presentation 1 |
| 12:20-12:45 Fertility preservation in borderline ovarian tumors; what if the contralateral ovary is ok? Nao Suzuki, Japan |
12:12-12:24 Oral presentation 2 |
| 12:24-12:36 Oral presentation 3 |
|
| 12:45-13:05 Freeze both ovaries in connection with bone marrow transplantation? – Pro and con Catherine Poirot, France |
12:36-12:48 Oral presentation 4 |
| 13:05-13:20 Q&A |
12:48-13:00 Oral presentation 5 |
| 13:00-13:15 Oral presentation 6 |
|
| 13:20-14:00 Lunch |
|
| Oncology afternoon | |
| 14:00-15:15 Session 4A: Fertility Preservation Hematological and Gynecological Cancers (Sylvester Cancer Center) Chairs: Stephen Nimer, USA and Pasquale Patrizio, USA |
14:00-15:15 Session 4B: Fertility Preservation in boys Chairs: Kyle Orwig, USA and Ellen Goossens, Belgium |
| 14:00-14:20 Genetic markers and therapeutic solutions for leukemia Stephen Nimer, USA |
14:00-14:20 Worldwide activity – amount of tissue frozen-methods Rod Mitchell, UK |
| 14:20-14:40 Ovarian tissue transplantation in acute leukemia: balancing the risk of relapses and the hope of parenthood Florian Chevillon, France |
14:20-14:40 Transplantation of adult frozen/thawed testicular tissue as a model to develop a method for fertility restoration Claus Yding Andersen, Denmark |
| 14:40-15:00 Fertility preservation in cervical cancer Abed Sinno, USA |
14:40-15:00 Obtaining chromosomal normal spermatogonial stem cells in Klinefelter Syndrome patients Hooman Sadri-Ardekani, USA |
| 15:00-15:15 Q&A |
15:00-15:15 Q&A |
| 15:15-16:30 Session 5A: Oncology-Breast Cancer patients and Fertility Preservation Chairs: Carmen Calfa, USA and Kenny Rodriguez-Wallberg, Sweden |
15:15-16:30 Session 5B: In Vitro Maturation of Human Oocytes in connection with freezing ovarian tissue Chairs: Liang Xiaoyan, China and Jesus Cadenas, Denmark |
| 15:15-15:35 Update on efficacy and safety of fertility preservation in patients with breast cancer Moran Shapira, Israel |
15:15-15:35 IVM experience from Vietnam Ho Tuong, Vietnam |
| 15:35-15:55 Oncologic and reproductive outcomes after fertility preservation in women with breast cancer – the needed long-term observation time Kenny Rodriguez-Wallberg, Sweden |
15:35-15:55 IVM in connection with OTC – experience from China Liang Xiaoyan, China |
| 15:55-16:15 How to expand coverage of fertility preservation: how to approach legislators and inclusion of patients Joyce Reinecke, USA |
15:55-16:15 Techniques for aspiration of human small antral follicles (2–5 mm) without general anesthesia Kristine Løssl, Denmark |
| 16:15-16:30 Q&A |
16:15-16:30 Q&A |
| 16:30-16:45 Coffee Break |
|
| 16:45-18:00 Session 6A: Fertility preservation: Testicular Tissue Cryopreservation and beyond Chairs: Rod Mitchell, UK and Hooman Sadri-Ardekani, USA |
16:45-18:00 Session 6B: Understanding human folliculogenesis Chairs: Debra Gook, Australia and Claus Yding Andersen, Denmark |
| 16:45-17:05 Indications – genetic conditions – cryptorchidism – cancer Emilie Johnson, USA |
16:45-17:05 Engineering strategies for the follicular micro-environment Monica Laronda, USA |
| 17:05-17:25 Experience with transplantation of prepubertal human testicular tissue Ellen Goossens, Belgium |
17:05-17:25 Update on progress of human in vitro follicle activation – any clinical solutions in sight? David Albertini, USA |
| 17:25-17:45 Fertility Preservation and Restoration with Testicular Tissues and Cells Kyle Orwig, USA |
17:25-17:45 New drugs/agonists to prevent or initiate initiation of follicular growth (AMH, GDF9, others) Laura Detti, USA |
| 17:45-18:00 Q&A |
17:45-18:00 Q&A |
| 19:00-22:00 Social Event |
|
| Saturday, Nov 21, 2026 | |
|---|---|
| Hall A | Hall B |
| 08:30-09:00 Honorary Lecture 3: Chairs: Dror Meirow, Israel and Claus Yding Andersen, Denmark Current status and potential for creating human artificial gametes Amander Clark, USA |
|
| 09:00-10:15 Session 7A: Ovarian Tissue Cryopreservation in Children and Adolescents Chairs: Kenny Rodriguez-Wallberg, Sweden and TBA |
09:00-10:15 Session 7B: AI in fertility preservation Chairs: Pasquale Patrizio, USA and Jung Ryeol Lee, South Korea |
| 09:00-09:20 Indications and worldwide activity of fertility preservation in prepubertal girls Elizabeth Ginsburg, USA |
09:00-09:20 Novel fertility preservation approaches using stem cells and exosomes Ayman Al-Handy, USA |
| 09:20-09:40 Fertility preservation in girls, OTC and OTT in girls with thalassemia and sickle cell anemia Liang Xiaoyan, China |
09:20-09:40 Use of AI and robotics combined with microscopy-/ultrasound to select for strips of the most follicle-rich tissue in procurement of ovarian tissue Ariella Shikanov, USA |
| 09:40-10:00 Freezing ovarian tissue from young prepubertal girls – technical aspects Claus Yding Andersen, Denmark |
09:40-10:00 Breakthroughs in fertility preservation: innovative approaches for immediate and long-term care Amir Arav, Israel |
| 10:00-10:15 Q&A |
10:00-10:15 Q&A |
| 10:15-10:45 Coffee Break |
|
| 10:45-12:00 Session 8A: Ovarian Tissue Transplantation Chairs: Nao Suzuki, Japan and Dror Meirow, Israel |
10:45-11:47 Session 8B: Oral Session of selected posters Chairs: Monica Laronda, USA and Kristin Smith, USA |
| 10:45-11:05 Ovarian tissue transplantation: Worldwide activity, results, and recurrence Michael von Wolff, Switzerland |
10:45-10:57 Oral presentation 1 |
| 11:05-11:25 Which site to transplant – does ovulation occur from the peritoneal pocket positioned tissue? Isabelle Demeestere, Belgium |
10:57-11:09 Oral presentation 2 |
| 11:09-11:21 Oral presentation 3 |
|
| 11:25-11:45 Cancer survivorship: enhancing well-being beyond cancer treatment Frank Penedo, USA |
11:21-11:33 Oral presentation 4 |
| 11:45-12:00 Q&A |
11:33-11:45 Oral presentation 5 |
| 11:45-11:57 Oral presentation 6 |
|
| 12:00-13:15 Session 9A: Longevity of ovarian function Chairs: Glenn Schattman, USA and Jung Ryeol Lee, South Korea |
12:00-13:12 Session 9B: Oral Session of selected posters Chairs: Claus Yding Andersen, Denmark and Zev Rosenwaks, USA |
| 12:00-12:20 Predictive markers for longevity of transplanted ovarian tissue – beyond age Debra Gook, Australia |
12:00-12:12 Oral presentation 1 |
| 12:20-12:45 Ex vivo ovarian perfusion: Folliculogenesis and oocyte retrievals after gonadotropins Pasquale Patrizio, USA |
12:12-12:24 Oral presentation 2 |
| 12:45-13:05 Understanding molecular mechanism of freeze-thaw injury after OTC and oocyte cryopreservation and how to improve preservation Wen Li, China |
12:24-12:36 Oral presentation 3 |
| 12:36-12:48 Oral presentation 4 |
|
| 13:05-13:20 Q&A |
12:48-13:00 Oral presentation 5 |
| 13:00-13:12 Oral presentation 6 |
|
| 13:20-14:00 Lunch |
|
| 14:00-15:15 Session 10A: Artificial Ovaries, artificial follicle formation, gonadal IPSc Chairs: Debra Gook, Australia and Monica Laronda, USA |
14:00-15:15 Session 10B: Oncology and fertility preservation Chairs: Kenny Rodriguez-Wallberg, Sweden and TBA |
| 14:00-14:20 Restoring steroidogenesis using hPSC-derived GPCs-initially for securing endocrine function after menopause? Daylon James, USA |
14:00-14:20 Hormonal replacement strategies in survivors of Gynecological cancers Abed Sinno, USA |
| 14:20-14:40 Artificial ovaries for fertility and hormone therapy Jung Ryeol Lee, South Korea |
14:20-14:40 Use of letrozole in ovarian stimulation for fertility preservation in women with estrogen sensitive tumors. Current evolution and therapeutic approaches to breast cancer Carmen Calfa, USA |
| 14:40-15:00 Induction of male neogametogenesis in a 3D microenvironment supporting successful fertilization and proper embryo development TBA |
14:40-15:00 Effects of letrozole during ovarian stimulation in circulation and in the follicle Claus Yding Andersen, Denmark |
| 15:00-15:15 Q&A |
15:00-15:15 Q&A |
| 15:15-16:30 Session 11A: Fertility Preservation in Endometriosis and Uterus Surgery Chairs: Tommaso Falcone, USA and Nao Suzuki, Japan |
15:15-16:27 Session 11B: Oral Session of selected posters Chairs: Jung Ryeol Lee, South Korea and Terri Woodard, USA |
| 15:15-15:35 Uterine surgery to preserve fertility through uterus conservation in fibromyomatosis/ adenomyosis Tommaso Falcone, USA |
15:15-15:27 Oral presentation 1 |
| 15:35-15:55 Uterus transplantation: An update Mats Brännström, Sweden |
15:27-15:39 Oral presentation 2 |
| 15:55-16:15 Fertility preservation in connection with endometriosis Tommaso Falcone, USA |
15:39-15:51 Oral presentation 3 |
| 15:51-16:03 Oral presentation 4 |
|
| 16:15-16:30 Q&A |
16:03-16:15 Oral presentation 5 |
| 16:15-16:27 Oral presentation 6 |
|
| 16:30-16:45 Coffee Break |
|
| 16:45-18:00 Session 12A: Cancer survivorship-Sylvester cancer center Chairs: Abed Sinno, USA and Roy Herbst, USA |
16:45-18:00 Session 12B: Understanding IVM Chairs: Liang Xiaoyan, China and Claus Yding Andersen, Denmark |
| 16:45-17:05 Supporting the reproductive health of adolescent girls who are pediatric cancer survivors Judy Simms-Cendan, USA |
16:45-17:05 How does CAPA-IVM work and is there other solutions to optimize oocyte maturation Ri-Cheng Chian, China |
| 17:05-17:25 Safety of pregnancy after breast cancer: what is current evidence TBA |
17:05-17:25 Two for one: Combining OTC with IVM from medullary antral follicles: results of combined approaches in Denmark Jesus Cadenas, Denmark |
| 17:25-17:45 Harnessing circadian biology to optimize cancer treatment response Tracy Crane, USA |
17:25-17:45 Does co-culture of hIPS cell-derived ovarian support cells improve IVM? Christian Kramme, USA |
| 17:45-18:00 Q&A |
17:45-18:00 Q&A |
| 18:00-18:30 Adjourn and Closing Ceremony Claus Yding Andersen, Denmark and Pasquale Patrizio, USA |
|
